In the News

February 19, 2019


The 100 Leading Pioneers Of AI Drug Development

The profile of these people is quite interesting as 43% of them come from Academia. It seems that some of the big brains of the planet have targeted their efforts on improving human life and possibly extending the lifespan. The impact of AI leaders in this category is characterized by a high number of peer-reviewed publications, a high level of citation, pioneering roles in theoretical or engineering of ML/AI for drug discovery, a notable theoretical breakthrough, a technical invention, or a widely adopted commercial model.

Read the full story at Forbes.

The 100 Leading Pioneers Of AI Drug Development

< Previous
CPRI Receives $1.4M Gift for Securing the Seams of the Internet of Everything
Next >
Australian citizens are unwitting ‘combatants’ in cyberspace, Defence boss says

Media interested in interviewing ICS faculty, students or alumni should contact Matt Miller at (949) 824-1562 or via email at